| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |